N P Peet - JoVE Visualize

Showing results (21-30 of 28) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 28 results.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1989

Pharmacokinetics and metabolism of a 4'-methylthio derivative of propranolol in the dogS A Bai, D E Easterling, M J Wilson, et al.

European Journal of Pharmacology|August 29, 1996

Activation of adenosine A3 receptors on macrophages inhibits tumor necrosis factor-alphaC D McWhinney, M W Dudley, T L Bowlin, et al.

The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994

Pharmacology of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N- [3,3,4,4,4-pentafluoro-1-(1-methylethyl)-2-oxobutyl]-L-prolinamide (MDL 101,146): a potent orally active inhibitor of human neutrophil elastaseS L Durham, C M Hare, M R Angelastro, et al.

Journal of Medicinal Chemistry|February 15, 2001

Crystal structure of human cyclin-dependent kinase 2 in complex with the adenine-derived inhibitor H717M K Dreyer, D R Borcherding, J A Dumont, et al.

Biochemistry|February 4, 1997

Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moietyJ A Malikayil, J P Burkhart, H A Schreuder, et al.

Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001

The design and synthesis of purine inhibitors of CDK2. IIIP W Shum, N P Peet, P M Weintraub, et al.

Bioorganic & Medicinal Chemistry Letters|September 7, 1999

Hydroxyoxazolidines as alpha-aminoacetaldehye equivalents: novel inhibitors of calpainN P Peet, H O Kim, A L Marquart, et al.

Journal of Medicinal Chemistry|July 3, 1998

Inhibition of human neutrophil elastase. 4. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of P2-modified, orally active peptidyl pentafluoroethyl ketonesR J Cregge, S L Durham, R A Farr, et al.

Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 28 results.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1989

Pharmacokinetics and metabolism of a 4'-methylthio derivative of propranolol in the dogS A Bai, D E Easterling, M J Wilson, et al.

European Journal of Pharmacology|August 29, 1996

Activation of adenosine A3 receptors on macrophages inhibits tumor necrosis factor-alphaC D McWhinney, M W Dudley, T L Bowlin, et al.

The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994

Pharmacology of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N- [3,3,4,4,4-pentafluoro-1-(1-methylethyl)-2-oxobutyl]-L-prolinamide (MDL 101,146): a potent orally active inhibitor of human neutrophil elastaseS L Durham, C M Hare, M R Angelastro, et al.

Journal of Medicinal Chemistry|February 15, 2001

Crystal structure of human cyclin-dependent kinase 2 in complex with the adenine-derived inhibitor H717M K Dreyer, D R Borcherding, J A Dumont, et al.

Biochemistry|February 4, 1997

Molecular design and characterization of an alpha-thrombin inhibitor containing a novel P1 moietyJ A Malikayil, J P Burkhart, H A Schreuder, et al.

Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001

The design and synthesis of purine inhibitors of CDK2. IIIP W Shum, N P Peet, P M Weintraub, et al.

Bioorganic & Medicinal Chemistry Letters|September 7, 1999

Hydroxyoxazolidines as alpha-aminoacetaldehye equivalents: novel inhibitors of calpainN P Peet, H O Kim, A L Marquart, et al.

Journal of Medicinal Chemistry|July 3, 1998

Inhibition of human neutrophil elastase. 4. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of P2-modified, orally active peptidyl pentafluoroethyl ketonesR J Cregge, S L Durham, R A Farr, et al.

Pageof 3